MYAGIOS Trademark

Trademark Overview

On Monday, April 9, 2018, a trademark application was filed for MYAGIOS with the United States Patent and Trademark Office. The USPTO has given the MYAGIOS trademark a serial number of 87868169. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, May 12, 2025. This trademark is owned by Agios Pharmaceuticals, Inc.. The MYAGIOS trademark is filed in the Insurance & Financial Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Patient support services to help eligible patients obtain access to or afford prescription drugs for the treatment of [ cancer and ] rare genetic diseases, namely, financial administration of pharmacy reimbursement programs and services; reimbursement payment processing in the field of insurance claims for pharmaceuticals

Charitable services, namely, patient assistance program to provide drugs at reduced cost or free of charge to low-income patients without prescription drug coverage
myagios

General Information

Serial Number87868169
Word MarkMYAGIOS
Filing DateMonday, April 9, 2018
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, May 12, 2025
Registration Number5760764
Registration DateTuesday, May 28, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 12, 2019

Trademark Statements

Description of MarkThe mark consists of the word "MY" in stylized lettering inside two intersecting arcs, and the word "AGIOS" in stylized lettering.
Pseudo MarkMY AGIOS
Goods and ServicesPatient support services to help eligible patients obtain access to or afford prescription drugs for the treatment of [ cancer and ] rare genetic diseases, namely, financial administration of pharmacy reimbursement programs and services; reimbursement payment processing in the field of insurance claims for pharmaceuticals
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesCharitable services, namely, patient assistance program to provide drugs at reduced cost or free of charge to low-income patients without prescription drug coverage

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, January 25, 2019
Primary Code036
First Use Anywhere DateFriday, July 20, 2018
First Use In Commerce DateFriday, July 20, 2018
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 25, 2019
Primary Code044
First Use Anywhere DateFriday, July 20, 2018
First Use In Commerce DateFriday, July 20, 2018

Trademark Owner History

Party NameAgios Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 021394169
Party NameAgios Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 021394169
Party NameAgios Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 021394169

Trademark Events

Event DateEvent Description
Thursday, April 12, 2018NEW APPLICATION ENTERED
Tuesday, April 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 18, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, July 27, 2018ASSIGNED TO EXAMINER
Friday, July 27, 2018NON-FINAL ACTION WRITTEN
Friday, July 27, 2018NON-FINAL ACTION E-MAILED
Friday, July 27, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 3, 2018TEAS AMENDMENT OF USE RECEIVED
Saturday, August 4, 2018USE AMENDMENT FILED
Saturday, August 4, 2018AMENDMENT TO USE PROCESSING COMPLETE
Monday, August 6, 2018USE AMENDMENT ACCEPTED
Tuesday, August 7, 2018NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, October 8, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 8, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 9, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 10, 2018FINAL REFUSAL WRITTEN
Wednesday, October 10, 2018FINAL REFUSAL E-MAILED
Wednesday, October 10, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 22, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 22, 2019EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, January 22, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, January 22, 2019EX PARTE APPEAL-INSTITUTED
Monday, January 28, 2019ASSIGNED TO LIE
Monday, January 28, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, January 28, 2019EXAMINERS AMENDMENT E-MAILED
Monday, January 28, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 28, 2019EXAMINER'S AMENDMENT ENTERED
Monday, January 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 29, 2019EXPARTE APPEAL TERMINATED
Friday, February 1, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, February 6, 2019ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, February 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, February 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 28, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 16, 2024TEAS SECTION 8 RECEIVED
Thursday, May 8, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 12, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, May 12, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

myagios services prescription drugs patients namely patient reimbursement insurance assistance claims